Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 632 publications

Tafamidis between real-world evidence and registration trials: towards a price renegotiation with a view to sustainability and appropriateness.

Tafamidis between real-world evidence and registration trials: towards a price renegotiation with a view to sustainability and appropriateness.

Journal: Recenti progressi in medicina
Published: December 15, 2025

Acoramidis (Beyonttra®) : a new era in the treatment of transthyretin amyloid cardiomyopathy

Acoramidis (Beyonttra®) : a new era in the treatment of transthyretin amyloid cardiomyopathy

Journal: Revue medicale de Liege
Published: December 15, 2025

A plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy.

A plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy.

Journal: Future cardiology
Published: December 12, 2025

Methods of identifying transthyretin amyloid cardiomyopathy in secondary data sources: a systematic review.

Methods of identifying transthyretin amyloid cardiomyopathy in secondary data sources: a systematic review.

Journal: Current medical research and opinion
Published: December 08, 2025

Diagnostic Performance and Interpreter Experience of 1-Hour Versus 3-Hour 99mTc-HMDP Cardiac Amyloid Radionuclide Imaging: A Prospective, Blinded Comparison.

Diagnostic Performance and Interpreter Experience of 1-Hour Versus 3-Hour 99mTc-HMDP Cardiac Amyloid Radionuclide Imaging: A Prospective, Blinded Comparison.

Journal: Circulation. Cardiovascular imaging
Published: December 08, 2025

Role SGLT2 inhibitor therapy in patients with transthyretin cardiac amyloidosis: a GRADE assessed systematic review and meta-analysis.

Role SGLT2 inhibitor therapy in patients with transthyretin cardiac amyloidosis: a GRADE assessed systematic review and meta-analysis.

Journal: Acta cardiologica
Published: December 05, 2025

Global Longitudinal Strain for Prognostic Staging in Wild-Type Transthyretin Cardiac Amyloidosis.

Global Longitudinal Strain for Prognostic Staging in Wild-Type Transthyretin Cardiac Amyloidosis.

Journal: Circulation. Cardiovascular imaging
Published: December 04, 2025

Transthyretin amyloid cardiomyopathy

Transthyretin amyloid cardiomyopathy

Journal: Ugeskrift for laeger
Published: November 28, 2025

Navigating the emerging landscape of asymptomatic ATTR-CM: challenges, opportunities and the path ahead.

Navigating the emerging landscape of asymptomatic ATTR-CM: challenges, opportunities and the path ahead.

Journal: Future cardiology
Published: November 28, 2025

A real-world study of tafamidis in people with transthyretin amyloid cardiomyopathy (ATTR-CM) with heart and nerve symptoms: a plain language summary.

A real-world study of tafamidis in people with transthyretin amyloid cardiomyopathy (ATTR-CM) with heart and nerve symptoms: a plain language summary.

Journal: Future cardiology
Published: November 26, 2025

The evolving landscape of screening, management and treatment strategies of aortic stenosis in ATTR amyloidosis.

The evolving landscape of screening, management and treatment strategies of aortic stenosis in ATTR amyloidosis.

Journal: European journal of internal medicine
Published: November 19, 2025

Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin Cardiomyopathy.

Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin Cardiomyopathy.

Journal: Journal of the American Heart Association
Published: November 12, 2025
Showing 1-12 of 632

Last Updated: 01/07/2026